EDV

Rivian Introduces R2, R3, and R3X Built on New Midsize Platform

Retrieved on: 
Thursday, March 7, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240307349103/en/
    Rivian introduces its midsize platform family: R2, R3 and R3X.
  • R3 is a midsize crossover that is tidy on dimensions but delivers big in terms of performance, off-road capability, passenger comfort, and storage.
  • R3X is a performance variant of R3 offering even more dynamic abilities both on and off road.
  • I can’t wait to get these to customers.”
    Developed to deliver amazing performance, range, and cost efficiency, R2 and R3 were built on an all-new midsize vehicle platform.

Rivian Releases Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, February 22, 2024

Rivian Automotive, Inc. (NASDAQ: RIVN) today announced fourth quarter and year end 2023 financial results.

Key Points: 
  • Rivian Automotive, Inc. (NASDAQ: RIVN) today announced fourth quarter and year end 2023 financial results.
  • Overall, there was a 147 percent increase in deliveries for the fourth quarter of 2023 as compared to the fourth quarter of 2022.
  • Gross profit was $(606) million for the fourth quarter of 2023, an improvement from $(1,000) million for the same quarter in 2022.
  • The decreased Adjusted EBITDA* loss for the fourth quarter of 2023 as compared to the fourth quarter of 2022 was driven by lower gross profit losses.

Celgard and Æsir Technologies Forge Strategic Alliance to Drive Industry Innovation in Nickel-Zinc, Zinc-Air and Lithium-Zinc Batteries

Retrieved on: 
Monday, January 29, 2024

CHARLOTTE, N.C., Jan. 29, 2024 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LLC (Polypore), is pleased to announce a newly formed Alliance with Æsir Technology, Inc. (Æsir), a leading manufacturing company that specializes in developing next-generation Nickel-Zinc battery technology.

Key Points: 
  • CHARLOTTE, N.C., Jan. 29, 2024 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LLC (Polypore), is pleased to announce a newly formed Alliance with Æsir Technology, Inc. (Æsir), a leading manufacturing company that specializes in developing next-generation Nickel-Zinc battery technology.
  • This chemistry offers a stable cost-effective recyclable option with energy density in between lithium-ion and lead-acid batteries, making it an ideal choice for many applications.
  • Celgard/Aesir alliance with planned gigafactory brings affordable cells to communications, EV and energy infrastructure.
  • Celgard will also be positioned to offer separator products to future Ni-Zn and Li-Zn Æsir licensees or joint ventures.

Celgard and Æsir Technologies Forge Strategic Alliance to Drive Industry Innovation in Nickel-Zinc, Zinc-Air and Lithium-Zinc Batteries

Retrieved on: 
Monday, January 29, 2024

CHARLOTTE, N.C., Jan. 29, 2024 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LLC (Polypore), is pleased to announce a newly formed Alliance with Æsir Technology, Inc. (Æsir), a leading manufacturing company that specializes in developing next-generation Nickel-Zinc battery technology.

Key Points: 
  • CHARLOTTE, N.C., Jan. 29, 2024 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LLC (Polypore), is pleased to announce a newly formed Alliance with Æsir Technology, Inc. (Æsir), a leading manufacturing company that specializes in developing next-generation Nickel-Zinc battery technology.
  • This chemistry offers a stable cost-effective recyclable option with energy density in between lithium-ion and lead-acid batteries, making it an ideal choice for many applications.
  • Together, Celgard and Æsir will collaborate on joint research projects to further develop high-technology next-generation Nickel-Zinc (Ni-Zn), Zinc-Air (Zn-Air), Lithium-Zinc (Li-Zn) and Sodium-Zinc (Na-Zn) batteries used primarily in aviation, data centers, telecom, energy infrastructure and electric vehicle (EV) charging applications.
  • Celgard will also be positioned to offer separator products to future Ni-Zn and Li-Zn Æsir licensees or joint ventures.

EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic

Retrieved on: 
Friday, December 8, 2023

Pancreatic ductal adenocarcinoma (PDAC) is a notoriously challenging and aggressive form of cancer, usually diagnosed in advanced stages, making curative treatment options limited.

Key Points: 
  • Pancreatic ductal adenocarcinoma (PDAC) is a notoriously challenging and aggressive form of cancer, usually diagnosed in advanced stages, making curative treatment options limited.
  • EnGeneIC’s EDV therapeutic is a first-in-class Antibody Nanocell Drug Conjugate (ANDC) which also promotes a robust anti-tumour immune response.
  • Unlike other ADCs (antibody drug conjugates), the EDV delivers its very large payload of cytotoxic drug directly inside the cancer cell.
  • The “Fast-Track” designation expedites the development and review process, allowing EnGeneIC to accelerate the EDV’s development for PDAC patients.

EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options

Retrieved on: 
Monday, November 27, 2023

The trial results highlight a significant advance in the treatment landscape for PDAC:

Key Points: 
  • The trial results highlight a significant advance in the treatment landscape for PDAC:
    Unprecedented Survival Rates.
  • The trial demonstrated a substantial increase in median overall survival for patients, with 88% of participants surpassing at least double the historical survival rates.
  • Remarkably, more than 80% of patients receiving the EDV treatment either maintained or experienced weight gain.
  • Joint-CEO and Director of EnGeneIC, Dr Jennifer MacDiarmid said, “We are very excited about the results of our Carolyn Trial.

November is Pancreatic Cancer Awareness Month

Retrieved on: 
Wednesday, November 8, 2023

EnGeneIC, an Australian/USA biotechnology company, has developed a proprietary targeted nanocell-based therapeutic focused on treatment of low survival solid-tumors, including PDAC.

Key Points: 
  • EnGeneIC, an Australian/USA biotechnology company, has developed a proprietary targeted nanocell-based therapeutic focused on treatment of low survival solid-tumors, including PDAC.
  • The nanocell (designated EDVTM; EnGeneIC Dream Vector) is best described as an Antibody-Nanocell-Drug-Conjugate (ANDC) which also stimulates a powerful anti-tumour immune response.
  • Amazingly, after 15 months of EDV therapy, the patient’s cancer has disappeared and this has been achieved with minimal side effects.
  • In fact, the patient’s quality of life improved so much that she was allowed EDV-treatment breaks for holidays in Paris and Hawaii.

The Climate Pledge and C40 Cities Partner to Launch Laneshift, an International Initiative to Decarbonize Freight Trucks in Developing Countries

Retrieved on: 
Tuesday, September 19, 2023

Road freight is a major source of air pollution and one of the most important sectors to decarbonize, but it’s also one of the most challenging.

Key Points: 
  • Road freight is a major source of air pollution and one of the most important sectors to decarbonize, but it’s also one of the most challenging.
  • Through Laneshift, The Climate Pledge, C40 Cities (a network of mayors from around the world), private and public sector stakeholders, city governments and non-government organizations will all work together to help equitably reduce and avoid greenhouse emissions.
  • Laneshift will bring together cities and businesses that are at the leading edge of climate action, through this unique partnership between C40 and The Climate Pledge.
  • This is the kind of collaboration that will be essential for success,” said Tom Rivett-Carnac, founding partner of Global Optimism.

Amazon Rolls Out First Electric Delivery Vans from Rivian in Europe

Retrieved on: 
Monday, July 3, 2023

Amazon today announced the arrival of its new custom electric delivery vans from Rivian in Europe, with the first vans rolling out in Germany.

Key Points: 
  • Amazon today announced the arrival of its new custom electric delivery vans from Rivian in Europe, with the first vans rolling out in Germany.
  • More than 300 electric delivery vans are hitting the road in Munich, Berlin, and Dusseldorf in the coming weeks, joining a fleet of thousands of electric vans already in operation in Europe, including more than 1,000 electric vans in Germany.
  • “Together, Amazon and Rivian designed and built a state-of-the-art electric vehicle from the ground up, and unlike anything else on the road today,” said Neil Emery, Amazon, Director, Global Fleet & Product.
  • Amazon’s custom electric delivery vans from Rivian are designed from the ground-up with safety, sustainability, and comfort in mind, and have been thoroughly tested by drivers in Germany.

Celgard Takes Another Step in Energy Storage Growth as It Forms Strategic Alliance with Lithion Battery for Next-generation Battery Cells

Retrieved on: 
Wednesday, June 7, 2023

CHARLOTTE, N.C., June 7, 2023 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LP (Polypore), is pleased to announce a newly formed strategic alliance with Lithion Battery, Inc. (Lithion), whereby the two companies will undertake joint development of battery separators for next generation lithium-ion cells with Lithium Iron Phosphate (LFP) cathode material.

Key Points: 
  • CHARLOTTE, N.C., June 7, 2023 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LP (Polypore), is pleased to announce a newly formed strategic alliance with Lithion Battery, Inc. (Lithion), whereby the two companies will undertake joint development of battery separators for next generation lithium-ion cells with Lithium Iron Phosphate (LFP) cathode material.
  • Through this collaborative effort, the companies will meet the ever-growing demand of supplying consistent power to those in need with energy storage systems (ESS) for uses such as micro-grid power applications.
  • The cells could also be deployed in medical tools and military and industrial markets, where Celgard has been providing separator solutions for decades.
  • Celgard will have the first opportunity to supply next-generation battery separator solutions to Lithion for all new battery developments.